CSL Behring Australia
The Director, Portfolio Development Process & Standards Lead establishes and maintains a global framework for planning, evaluating, and reporting clinical trials under high-quality standards. This role drives cross-functional process improvements, manages SOP updates, and ensures compliance within CSL's biopharma R&D organization. Based in King of Prussia, Waltham, or Maidenhead, the position requires extensive experience in drug development and clinical research.
CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives. We manufacture remedies for rare and serious conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CSL Behring Australia.
47% above the average for this role
Principal Statistician
CSL
Principal Biostatistician X3
CSL
Director, Global Clinical Program Leader, Immunoglobulins
CSL
Sr. Clinical Research Associate
Parexel
Single Sponsor Clinical Project Manager II (Virology) - 3 days a week in Uxbridge.
Syneos Health
Senior Medical Director, Kidney Disease, Early Clinical Development CVRM
American Association of Physicists in Medicine